Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from CVS Health

CVS Health Earnings Top Forecasts as Health-Care-Benefits Revenue Surges

"Last year was defined by outperformance across our foundational businesses," said CEO Karen Lynch.

The Street

CVS Health Confirms $10.6 billion Takeover Of Oak Street Health

"Combining Oak Street Health's platform with CVS Health's unmatched reach will create the premier value-based primary care solution," said CVS CEO Karen Lynch.

The Street

Value Stocks Are Still Beating Growth — Analysts Like These 5 Best

Some speculative S&P 500 stocks may be getting some lift this year. But make no mistake — value stocks are still in control.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Owning These 3 Stocks Could Make You Rich in 10 Years

Consistently falling prices and stronger-than-expected fourth-quarter GDP are renewing hopes about the economy’s overall health. Therefore, it could be wise to add quality stocks with solid fundamentals, Walmart (WMT), Bristol-Myers Squibb (BMY), and CVS Health (CVS), to your portfolio to garner substantial returns in 10 years. Read more….

StockNews.com

5 Unstoppable Stocks You Shouldn't Wait Any Longer to Buy

The Fed’s intention to keep raising interest rates despite the cooling down of inflation could eventually lead to the economy witnessing a recession. Moreover, the World Bank lowered its 2023 global growth forecast by almost half, citing deteriorating economic conditions. Hence, it could be wise to invest in fundamentally sound…

StockNews.com

CVS Health May Buy Oak Street Health. Should You Buy CVS Stock?

CVS Health is reportedly exploring a $10 billion deal to buy Oak Street Health. Will that make CVS stock a buy?

The Street

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Health Care Stocks That Could Help You Make a Fortune

Although inflation is showing signs of cooling down and the Fed indicated a slower pace of interest rate hikes, recession fears loom. Thanks to the resilient demand for its products and services, the healthcare industry is expected to survive a challenging macroeconomic environment better than many industries. Thus, it could…

StockNews.com

4 Stocks With More Room to Run in 2023

Inflation eased again in November, which could allow the Fed to slow interest-rate hikes into the following year. Overall, the odds of the economy avoiding an anticipated recession are increasing. Given this backdrop, quality stocks CVS Health (CVS), ADT (ADT), ODP Corporation (ODP), and Universal Logistics (ULH) will likely see…

StockNews.com

The 4 Fastest-Growing Stocks to Purchase Right Now

Markets have been highly volatile this year due to macroeconomic and geopolitical headwinds. However, signs of slowing inflation and dovish comments from the Fed Chair have renewed investor appetite for riskier assets. Hence, it could be wise to invest in the fastest-growing stocks, CVS Health (CVS), McKesson (MCK), Celestica (CLS),…

StockNews.com

How the best leaders are preparing to navigate a recession—and come out ahead

Current and former corporate leaders share their battle-tested playbooks with Fortune.

Fortune

3 Hot Stocks With More Room to Run in 2023

As inflation shows signs of easing and the Fed is expected to slow the pace of rate hikes, the market’s prospects look bright. Therefore, fundamentally strong stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Box (BOX) could keep soaring. Wall Street analysts expect upsides in these stocks over the next 12…

StockNews.com

CVS Health Stock Clears Key Benchmark, Hitting 80-Plus RS Rating

A Relative Strength Rating upgrade for CVS Health shows improving technical performance.

Investors Business Daily

The 4 Best Growth Stocks to Buy Into 2023

With the Fed indicating that the pace of rate hikes might slow down, growth stocks could see a rebound. Therefore, it could be wise to buy CVS Health (CVS), Archer-Daniels-Midland (ADM), The Mosaic Company (MOS), and MaxLinear (MXL), which possess solid growth attributes. Keep reading….

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Walmart offers to pay $3.1 billion to settle opioid lawsuits

The retail giant becomes the latest major player in the drug industry to announce a plan to settle lawsuits filed by state and local governments over the toll of opioids sold at its pharmacies.

StockNews.com

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

France 24

US pharmacies announce opioid settlements totaling $10 billion

The two largest US pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle on Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids, and a lawyer said Walmart, a third pharmacy behemoth, is in discussions for a deal.

Benzinga

CVS Health Unusual Options Activity

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100’s of premium titles.
One news app.

AFP

US pharmacy chains to pay $10 bn to settle opioid cases

New York (AFP) - US pharmacy chains CVS Health and Walgreens said Wednesday they had reached preliminary agreements to together pay more than $10 billion to resolve opioid claims from US states, cities and tribes.

WEKU

CVS and Walgreens announce opioid settlements totaling $10 billion

It could amount to the last round of huge settlements after years of litigation over the industry's role in an overdose crisis linked to more than 500,000 deaths in the U.S. over the past two decades.

Benzinga

Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02

Reuters

AFP

US pharmacy chain CVS to pay $5 bn in opioid settlement

New York (AFP) - US pharmacy chain CVS Health said Wednesday they had agreed to pay approximately $5 billion over 10 years to "resolve all opioid lawsuits and claims" against them by states and cities.

The Independent UK

CVS Health agrees to $5B settlement of opioid lawsuits

CVS Health says it has agreed to pay about $5 billion to state, local and Native American tribal governments to settle lawsuits over the toll of opioids

Benzinga

Check Out What Whales Are Doing With CVS

Someone with a lot of money to spend has taken a bullish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The Independent UK

CVS to reduce prices of menstrual products and cover the sales tax: ‘Women deserve quality’

‘We’ve reduced the price on CVS Health brand period products by 25 per cent in core CVS Pharmacy locations,’ the pharmacy said in a satement

1 … 4 5 6 7

People

Elon Musk

18,998 stories

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

506 stories

Walgreens

442 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.